Jake Jorgovan

FEBRUARY 2, 2025

Updated: February 2025 "Medicine is a science of uncertainty and an art of probability." - William Osler. MWA Consulting: Is dedicated to upholding GXP quality and regulatory compliance in the pharmaceutical, medical device, and biotechnology industries.

Life science 130

Life science Biopharmaceuticals Biotech Partnering capability and readiness 130

Frost & Sullivan

MARCH 28, 2025

The pharmaceutical and biotechnology industries are at the cusp of a transformative era in 2025, driven by cutting-edge innovation, evolving regulations, and increasing market pressures. “The pharmaceutical and biotechnology industries are at a pivotal moment, where cutting-edge innovation meets increasing market demands.

Biotech 52

Biotech Biotechnology Strategic partnership Insurance 52

Frost & Sullivan

MARCH 13, 2025

The landscape of global molecular biomarkers is rapidly evolving, driven by advancements in biotechnology and the increasing demand for personalized medicine. Companies must navigate regulatory challenges, leverage AI for biomarker precision, and invest in strategic partnerships to stay ahead.

Biotechnology 52

Biotechnology Strategic partnership 52

Frost & Sullivan

FEBRUARY 12, 2025

13 th February 2025 Frost & Sullivan recently analyzed the biotechnology contract research organization (CRO) industry and, based on its findings, recognizes Southern Star Research with the 2024 Asia-Pacific Competitive Strategy Leadership Award. SAN ANTONIO, TX.

Biotech 52

Biotech Contract research organization Biotechnology Strategic alliances 52

Frost & Sullivan

FEBRUARY 5, 2025

February 5, 2025 Frost & Sullivan recently assessed the clinical sample analysis services industry and, based on its findings, recognizes Global Clinical Central Lab ( GCCL ) with the 2025 Asia-Pacific Customer Value Leadership Award. SAN ANTONIO, TX.

Biotechnology 59

Biotechnology Strategic partnership Life science 59